SELLAS Life Sciences Group, Inc.
SLSNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.15B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.39$15.88
- Volume (live)
- -
- Avg. volume (3M)
- 6.07M
SELLAS Life Sciences Group (SLS) Stock Price & Financial Analysis
SELLAS Life Sciences Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.75 - $11.24 |
|---|---|
| 52-Week High | $15.88 |
| 52-Week Low | $1.39 |
| Open | $11.20 |
| Volume (last close) | 15.82M |
| Average Volume (3M) | 6.07M |
| 50-Day MA | $12.47 |
|---|---|
| 200-Day MA | $8.15 |
| 1-Year Change | +429.91% |
| Market Cap | 2.15B |
|---|---|
| Shares Outstanding | 189.18M |
| Price to Book (P/B) | 15.58 |
| EV/EBITDA | -58.41 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
SELLAS Life Sciences Group at a Glance
As of the Oct 16, 2026 close, SELLAS Life Sciences Group (SLS) has a market capitalization of $2.15B.
As of its latest reported balance sheet, it holds $138.34M in cash and securities against $737.00K of debt, a net cash position of $137.61M.
SELLAS Life Sciences Group does not currently pay a dividend.
The share price is up 429.9% over the past year. At $9.98 (the Oct 16, 2026 close) it sits within its 52-week range of $1.39 to $15.88, above its 200-day moving average of $8.15.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About SELLAS Life Sciences Group
What is the current stock price for SLS?
As of the Oct 16, 2026 close, SLS stock trades at $9.98. The 52-week range is $1.39–$15.88, with a day range of $9.75–$11.24.
What is the P/E ratio for SLS?
The P/E ratio (Price-to-Earnings) for SLS is shown in the Key Statistics section. This valuation metric helps compare SELLAS Life Sciences Group, Inc. to industry peers.
Does SLS pay dividends?
SELLAS Life Sciences Group does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SLS?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for SLS is Buy.
What is the market cap of SLS?
As of the Oct 16, 2026 close, SELLAS Life Sciences Group's market capitalization is $1.89B, classifying it as a small-cap company. SELLAS Life Sciences Group operates in the Healthcare sector within the Biotechnology industry.